Literature DB >> 32304646

SARS-CoV-2 shedding and infectivity - Authors' reply.

Fei Zhou1, Guohui Fan2, Zhibo Liu1, Bin Cao3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32304646      PMCID: PMC7159864          DOI: 10.1016/S0140-6736(20)30869-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
We thank Barry Atkinson and Eskild Petersen for their comments on our Article describing the clinical course and risk factors for mortality of adult inpatients with coronavirus disease 2019 (COVID-19) in Wuhan, China. We agree that the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA in a respiratory specimen cannot be directly interpreted as a potential for disease transmission and infection. Although viral culture is an important method to evaluate viral infectivity and activity, it is unavailable in clinical practice because of its low sensitivity and long turn-around time for virus detection. Two negative SARS-CoV-2 RNA PCR tests, at least 24 h apart, was recommended by WHO as one of several criteria for discharge. Prolonged periods of detectable SARS-CoV-2 RNA suggest a sustained viral replication in some kinds of host cells in patients with COVID-19. A comparison has previously been made between viral shedding, as quantified by real time PCR (RT-PCR), and median tissue culture infectious dose (TCID50) in patients with influenza. The temporal changes in viral load by RT-PCR were similar to that of TCID50. For COVID-19, the association between viral load in respiratory tract specimens, quantified by RT-PCR, and viral culture needs evaluation. Viral activity is only one of various factors that might influence disease transmission. Epidemiology is the gold standard to measure transmission potential of patients who recover from COVID-19 yet are still positive for SARS-CoV-2 RNA. Further effort is urgently needed to evaluate the basic reproductive number in these patients.
  3 in total

1.  The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections.

Authors:  Dennis K M Ip; Lincoln L H Lau; Kwok-Hung Chan; Vicky J Fang; Gabriel M Leung; Malik J S Peiris; Benjamin J Cowling
Journal:  Clin Infect Dis       Date:  2015-10-30       Impact factor: 9.079

2.  Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections.

Authors:  Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

3.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

  3 in total
  8 in total

Review 1.  Transmission of SARS-CoV-2 by Children.

Authors:  Joanna Merckx; Jeremy A Labrecque; Jay S Kaufman
Journal:  Dtsch Arztebl Int       Date:  2020-08-17       Impact factor: 5.594

Review 2.  Echocardiography and Multimodality Cardiac Imaging in COVID-19 Patients.

Authors:  Alberto Cresti; Agata Barchitta; Andrea Barbieri; Ines Paola Monte; Giuseppe Trocino; Quirino Ciampi; Sofia Miceli; Licia Petrella; Emilija Jaric; Marco Solari; Cristina Basso; Mauro Pepi; Francesco Antonini-Canterin
Journal:  J Cardiovasc Echogr       Date:  2020-10-27

Review 3.  SARS-CoV-2 Tests: Bridging the Gap between Laboratory Sensors and Clinical Applications.

Authors:  Nikita Toropov; Eleanor Osborne; Lovleen Tina Joshi; James Davidson; Caitlin Morgan; Joseph Page; Justin Pepperell; Frank Vollmer
Journal:  ACS Sens       Date:  2021-08-14       Impact factor: 7.711

4.  COVID-19 in Recent Lung Transplant Recipients: Clinical Outcomes and Management Strategies.

Authors:  Julia Zimmermann; Olaf M Glueck; Jan M Fertmann; Wulf G Sienel; Gökce Yavuz; Fuad Damirov; Julia R Kovács; Amanda Tufman; Michael Irlbeck; Nikolaus Kneidinger; Sebastian Michel; Teresa Kauke; Rudolf A Hatz; Christian P Schneider
Journal:  Transplant Proc       Date:  2022-01-10       Impact factor: 1.014

5.  Systematic analysis and comparison of O-glycosylation of five recombinant spike proteins in β-coronaviruses.

Authors:  Xuefang Dong; Xiuling Li; Cheng Chen; Xiaofei Zhang; Xinmiao Liang
Journal:  Anal Chim Acta       Date:  2022-09-16       Impact factor: 6.911

Review 6.  Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature.

Authors:  Catharina Korsukewitz; Stephen W Reddel; Amit Bar-Or; Heinz Wiendl
Journal:  Nat Rev Neurol       Date:  2020-07-08       Impact factor: 44.711

7.  Culture-Based Virus Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19.

Authors:  Chung-Guei Huang; Kuo-Ming Lee; Mei-Jen Hsiao; Shu-Li Yang; Peng-Nien Huang; Yu-Nong Gong; Tzu-Hsuan Hsieh; Po-Wei Huang; Ya-Jhu Lin; Yi-Chun Liu; Kuo-Chien Tsao; Shin-Ru Shih
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

8.  Ct value is not enough to discriminate patients harbouring infective virus.

Authors:  María Pilar Romero-Gómez; Silvia Gómez-Sebastian; Emilio Cendejas-Bueno; María Dolores Montero-Vega; Jesús Mingorance; Julio García-Rodríguez
Journal:  J Infect       Date:  2020-11-26       Impact factor: 6.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.